Palisade Bio (PALI) Operating Income Growth (5y) (2015 - 2026)
Palisade Bio (PALI) Operating Income Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,725.60 Bn | 68,725.31 Bn | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 472.73 Bn | 467.94 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.52 Bn | 116.27 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.74 Bn | 60.99 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - |
| 8 | Argenx Se | 56.42 Bn | 51.24 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.76 Bn | 37.76 Bn | - |
| 10 | Palisade Bio | 422.47 Mn | 289.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40.63% |
| Dec 31, 2025 | -25.20% |
| Sep 30, 2025 | -9.98% |
| Jun 30, 2025 | -9.08% |
| Mar 31, 2025 | -3.02% |
| Dec 31, 2024 | -9.66% |
| Sep 30, 2024 | -11.08% |
| Jun 30, 2024 | -17.03% |
| Mar 31, 2024 | -8.38% |
| Dec 31, 2023 | -11.81% |
| Sep 30, 2023 | -12.65% |
| Jun 30, 2023 | -12.27% |
| Mar 31, 2023 | -1.49% |
| Dec 31, 2022 | -11.14% |
| Sep 30, 2022 | -11.26% |
| Jun 30, 2022 | 3.27% |
| Mar 31, 2022 | 1.68% |
| Dec 31, 2021 | 6.55% |
| Sep 30, 2021 | 9.31% |
| Jun 30, 2021 | -53.67% |